Adverse neonatal effects of maternal labetalol treatment

被引：11
|
作者：
Crooks, BNA [1 ]
Deshpande, SA [1 ]
Hall, C [1 ]
Platt, MPW [1 ]
Milligan, DWA [1 ]
机构：
[1] Royal Victoria Infirm, Newcastle Neonatal Serv, Special Care Baby Unit, Dept Pharm, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England
来源：
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION | 1998年 / 79卷 / 02期
关键词：
labetalol; hypotension; hypoglycaemia;
D O I：
10.1136/fn.79.2.F150
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
Two infants with features of severe beta adrenergic blockade, pericardial effusions, and myocardial hypertrophy were born to mothers receiving long term treatment with oral labetalol for hypertension in pregnancy. Labetalol was implicated in the aetiology of these problems. Pericardial effusion and myocardial hypertrophy have not been associated with labetalol toxicity in neonates.
引用
收藏
页码：F150 / F151
页数：2
相关论文
共 50 条
  • [1] NEONATAL SIDE EFFECTS OF MATERNAL LABETALOL TREATMENT IN SEVERE PREECLAMPSIA
    Hulzebos, C.
    Heida, K.
    Zeeman, G.
    ACTA PAEDIATRICA, 2009, 98 : 158 - 158
  • [2] Neonatal side effects of maternal labetalol treatment in severe preeclampsia
    Heida, Karst Y.
    Zeeman, Gerda G.
    Van Veen, Teelkien R.
    Hulzebos, Christian V.
    EARLY HUMAN DEVELOPMENT, 2012, 88 (07) : 503 - 507
  • [3] Neonatal Side Effects of Maternal Labetalol Treatment in Severe Preeclampsia.
    Heida, Karst Y.
    Zeeman, Gerda G.
    Hulzebos, Christian V.
    REPRODUCTIVE SCIENCES, 2010, 17 (03) : 128A - 129A
  • [4] FETAL AND NEONATAL CARDIOVASCULAR EFFECTS OF MATERNAL LABETALOL THERAPY USED IN THE TREATMENT OF PREGNANCY INDUCED HYPERTENSION
    WALKER, J
    CROOKS, A
    HOUSTON, A
    CALDER, AA
    CLINICAL AND EXPERIMENTAL HYPERTENSION PART B-HYPERTENSION IN PREGNANCY, 1982, 1 (2-3): : 223 - 223
  • [5] SEVERE ADVERSE-EFFECTS OF MATERNAL LABETALOL IN A PREMATURE-INFANT
    HARALDSSON, A
    GEVEN, W
    ACTA PAEDIATRICA SCANDINAVICA, 1989, 78 (06): : 956 - 958
  • [6] NEONATAL HYPOGLYCEMIA AFTER MATERNAL USE OF LABETALOL
    Blomjous, B. S.
    Sie, S. D.
    van Weissenbruch, M. M.
    INTENSIVE CARE MEDICINE, 2013, 39 : S150 - S150
  • [7] Adverse effects of young maternal age on neonatal outcomes
    Kang, Gavrielle
    Lim, Jia Yi
    Kale, Anita Sugam
    Lee, Le Ye
    SINGAPORE MEDICAL JOURNAL, 2015, 56 (03) : 157 - 163
  • [8] NEONATAL EFFECTS OF MATERNAL CLOMIPRAMINE TREATMENT
    OSTERGAARD, GZ
    PEDIATRICS, 1982, 69 (02) : 233 - 234
  • [9] Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis
    Bowman, ML
    Bergmann, M
    Smith, JF
    THYROID, 1998, 8 (09) : 795 - 796
  • [10] EFFECTS OF LABETALOL ON COCAINE PHARMACOKINETICS IN NEONATAL PIGLETS
    SCALZO, FM
    PRIMOZIC, S
    BURGE, LJ
    BADGER, TM
    CREER, MH
    NEHUS, C
    KARBA, R
    DEVELOPMENTAL PHARMACOLOGY AND THERAPEUTICS, 1993, 20 (1-2): : 54 - 63
12345